A predictive medicine product for hereditary pancreatic and related cancers.

PANEXIA^® is a genetic test specifically created for pancreatic cancer patients, offering insight about the risk of future hereditary cancers for patients and their families. PANEXIA analyzes the PALB2 and BRCA2 genes, the two genes most commonly identified in families with hereditary pancreatic cancer.

PANEXIA test results provide information for patients and their family members about the inherited risks of pancreatic cancer as well as breast, ovarian, and other cancers. This knowledge may allow at-risk family members the opportunity to lower their risks for some of these cancers through surveillance, preventative options, or lifestyle choices.

For more information, please contact Myriad’s Medical Services by calling 800-4-MYRIAD (800-469-7423).